Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shana Berwick"'
Publikováno v:
Cancer Research. 83:P4-07
Background: Contralateral axillary lymph node metastasis (CAM) in breast cancer (BC) is uncommon with an incidence of 1.9-6%. It is considered as stage IV disease based on the TNM classification in the 8th edition of the American Joint Committee on C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f1b1247fa33d3010a64cf54c3441884
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-59
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-59
Autor:
Shana Berwick, Hila Calev, Margaret M. Hayes, C. Christopher Smith, Brian R Poole, Andrew Matthews, Amrita Mukhopadhyay, Jordan Talan
Publikováno v:
Academic Medicine. 96:869-875
Purpose Evaluation of the medical profession at all levels has exposed episodes of gender-based role misidentification whereby women physicians are disproportionately misidentified as nonphysicians. The authors of this study investigate this phenomen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bdf4158b9daa697b351d7125f0ea515
https://doi.org/10.1097/acm.0000000000004060
https://doi.org/10.1097/acm.0000000000004060
Autor:
Iman Makki, Sangeetha Venugopal, Maaike van Gerwen, Qian Qin, Santiago Thibaud, Francine R. Dembitzer, Douglas Tremblay, Krina Christian, Tomi Jun, Mathilda Alsen, Shana Berwick, Sirish Dharmapuri, Erin Moshier, Jonathan Feld, Nicole Zubizarreta, Alaina J. Kessler, Leonard Naymagon, John Mascarenhas, Sheena Bhalla
Publikováno v:
Thrombosis Research
Observational data suggest an acquired prothrombotic state may contribute to the pathophysiology of COVID-19. These data include elevated D-dimers observed among many COVID-19 patients. We present a retrospective analysis of admission D-dimer, and D-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2eb45c1a9c2bd4e7386af7895f34158
http://europepmc.org/articles/PMC7439969
http://europepmc.org/articles/PMC7439969
Autor:
Douglas Tremblay, Andrew Dunn, John Mascarenhas, Jonathan Feld, Shana Berwick, Sirish Dharmapuri, Maaike van Gerwen, Sangeetha Venugopal, Leonard Naymagon, Santiago Thibaud, William Oh, Tomi Jun, Qian Qin, Alaina J. Kessler, Sheena Bhalla, Kevin Troy, Caroline Cromwell, Mathilda Alsen, Iman Makki
Publikováno v:
Blood
Tremblay and colleagues asked whether patients receiving either routine anticoagulation or antiplatelet therapy for existing conditions prior to becoming ill with COVID-19 have different outcomes from patients receiving neither therapy. After matchin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0ab996afd255dbf1364b8648da6d3b2
http://europepmc.org/articles/PMC7332896
http://europepmc.org/articles/PMC7332896
Publikováno v:
American Journal of Hematology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc16619121eb13b098b2eac836089905
https://doi.org/10.1002/ajh.25868
https://doi.org/10.1002/ajh.25868
Autor:
Brittney S Zimmerman, Krystal Pauline Cascetta, Amy Tiersten, Erin Moshier, Asem Berkalieva, Sara Malin Hovstadius, Shabnam Jaffer, Shana Berwick, Natalie F Berger, Julia Blanter
Publikováno v:
Journal of Clinical Oncology. 39:e12522-e12522
e12522 Background: Oncotype RS is a 21-gene assay used to predict the risk of recurrence and benefit from chemotherapy in early-stage, hormone positive (HR+), node-negative breast cancer (BC). The TAILORx trial showed that many patients with RS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55d7fd65017a4f23bf8bf80d8b7c07da
https://doi.org/10.1200/jco.2021.39.15_suppl.e12522
https://doi.org/10.1200/jco.2021.39.15_suppl.e12522
Autor:
Brittney S Zimmerman, Shabnam Jaffer, Shana Berwick, Amy Tiersten, Krystal Pauline Cascetta, Natalie F Berger, Danielle Seidman, Julia Blanter, Sara Malin Hovstadius, Asem Berkalieva, Erin Moshier, Alaina J. Kessler
Publikováno v:
Journal of Clinical Oncology. 39:e12511-e12511
e12511 Background: The RSClin model, which incorporates the Oncotype Recurrence Score (RS) and clinicopathologic features, was recently developed to further tailor prognosis and prediction of chemotherapy benefit for patients with early-stage hormone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06028fe13993f09845eddf4b8c6999fb
https://doi.org/10.1200/jco.2021.39.15_suppl.e12511
https://doi.org/10.1200/jco.2021.39.15_suppl.e12511